Literature DB >> 17129511

Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.

Robin A P Weir1, John J V McMurray.   

Abstract

The development of heart failure and/or left ventricular systolic dysfunction has long been regarded as an ominous complication, significantly increasing the morbidity and short- and long-term mortality of survivors of acute myocardial infarction. Although the incidence of heart failure after myocardial infarction has fallen over the last few decades, it remains common, complicating up to 45% of infarcts. Moreover, up to 60% of myocardial infarcts will result in left ventricular systolic dysfunction, depending on the exact definition used. Those at greatest risk of developing heart failure are the elderly, females, and those with prior myocardial infarction. Advances in the management of acute myocardial infarction have led to reduced in-hospital mortality (even when complicated by heart failure), but longer-term mortality remains high in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 17129511     DOI: 10.1007/s11897-006-0019-5

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  40 in total

1.  A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).

Authors:  D Hasdai; S Behar; L Wallentin; N Danchin; A K Gitt; E Boersma; P M Fioretti; M L Simoons; A Battler
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

2.  Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction.

Authors:  Amir Kashani; Robert P Giugliano; Elliott M Antman; David A Morrow; C Michael Gibson; Sabina A Murphy; Eugene Braunwald
Journal:  Eur Heart J       Date:  2004-10       Impact factor: 29.983

3.  Left ventricular assessment in myocardial infarction: the VALIANT registry.

Authors:  Adrian F Hernandez; Eric J Velazquez; Scott D Solomon; Rakhi Kilaru; Rafael Diaz; Christopher M O'Connor; George Ertl; Aldo P Maggioni; Jean-Lucien Rouleau; Wiek van Gilst; Marc A Pfeffer; Robert M Califf
Journal:  Arch Intern Med       Date:  2005-10-10

4.  Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.

Authors:  S Capewell; B M Livingston; K MacIntyre; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; C J Evans; J J McMurray
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

5.  Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study.

Authors:  U C Guidry; J C Evans; M G Larson; P W Wilson; J M Murabito; D Levy
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

Review 6.  Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.

Authors:  Robin A P Weir; John J V McMurray; Eric J Velazquez
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

7.  An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.

Authors:  Eric J Velazquez; Gary S Francis; Paul W Armstrong; Phillip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; John J V McMurray; Marc A Pfeffer; Robert M Califf
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

8.  Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction.

Authors:  Frederick A Spencer; Theo E Meyer; Joel M Gore; Robert J Goldberg
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

9.  Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.

Authors:  David Hasdai; Eric J Topol; Rakhi Kilaru; Alexander Battler; Robert A Harrington; Alec Vahanian; E Magnus Ohman; Christopher B Granger; Frans Van de Werf; Maarten L Simoons; Christopher M O'connor; David R Holmes
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

10.  One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry).

Authors:  Andrew T Yan; Mary Tan; David Fitchett; Chi-Ming Chow; Ronald A Fowlis; Thomas G McAvinue; Matthew T Roe; Eric D Peterson; Jack V Tu; Anatoly Langer; Shaun G Goodman
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  16 in total

Review 1.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

2.  β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats.

Authors:  Santosh K Shukla; Suman B Sharma; Usha R Singh
Journal:  Indian J Clin Biochem       Date:  2014-01-23

3.  Engineered Tissue Patch for Cardiac Cell Therapy.

Authors:  Jianyi Zhang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-08

4.  Protective effects of Jiashen Prescription () on myocardial infarction in rats.

Authors:  Ming-Jun Zhu; You-Ping Wang; Shi-Yang Xie; Wei-Hong Liu; Bin Li; Yong-Xia Wang; He Wang; Bo-Li Zhang
Journal:  Chin J Integr Med       Date:  2014-05-10       Impact factor: 1.978

5.  Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction.

Authors:  Francisco Azuaje; Yvan Devaux; Daniel R Wagner
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

6.  Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Authors:  Sana M Al-Khatib; Anne S Hellkamp; Gregg C Fonarow; Daniel B Mark; Lesley H Curtis; Adrian F Hernandez; Kevin J Anstrom; Eric D Peterson; Gillian D Sanders; Hussein R Al-Khalidi; Bradley G Hammill; Paul A Heidenreich; Stephen C Hammill
Journal:  JAMA       Date:  2014-06-04       Impact factor: 56.272

7.  The effects of mechanical stress on the growth, differentiation, and paracrine factor production of cardiac stem cells.

Authors:  Hiroshi Kurazumi; Masayuki Kubo; Mako Ohshima; Yumi Yamamoto; Yoshihiro Takemoto; Ryo Suzuki; Shigeru Ikenaga; Akihito Mikamo; Koichi Udo; Kimikazu Hamano; Tao-Sheng Li
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

8.  Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis.

Authors:  Yunpeng Qi; Haiwei Gu; Yunlong Song; Xin Dong; Aijun Liu; Ziyang Lou; Guorong Fan; Yifeng Chai
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-26       Impact factor: 2.629

9.  Left ventricular markers of global dyssynchrony predict limited exercise capacity in heart failure, but not in patients with preserved ejection fraction.

Authors:  Gani Bajraktari; Arlind Batalli; Afrim Poniku; Artan Ahmeti; Rozafa Olloni; Violeta Hyseni; Zana Vela; Besim Morina; Rina Tafarshiku; Driton Vela; Premtim Rashiti; Edmond Haliti; Michael Y Henein
Journal:  Cardiovasc Ultrasound       Date:  2012-09-11       Impact factor: 2.062

Review 10.  Prophylactic lidocaine for myocardial infarction.

Authors:  Arturo J Martí-Carvajal; Daniel Simancas-Racines; Vidhu Anand; Shrikant Bangdiwala
Journal:  Cochrane Database Syst Rev       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.